Exponent Inc

EXPO remains in a Stage 2 advancing phase with clear higher highs and higher lows, supported by rising EMAs, constructive volume, and steady momentum. Both medium- and long-term biases are bullish, but the stock is currently extended and near resistance with RSI approaching overbought. Optimal engagement is on a pullback into the $70–68 zone around the 9/20 EMAs, deferring execution until price shows acceptance there.

• ↑Revenue up 21% YoY to $171.6M in Q2 2026, driven by AI user research.
• ↑Net income rose 11% YoY to $29.4M; EBITDA margin of 28.7%.
• ↓Elevated leverage may strain debt servicing if rates rise further.